Loading…
Serologic markers in early stages of African horse sickness virus infection
Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to deve...
Saved in:
Published in: | Journal of Clinical Microbiology 1997-02, Vol.35 (2), p.531-535 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c561t-4ab7dd91d94af8b32a36115e6b5ad1086679bf762b0f55aa1de8177422e6ca053 |
---|---|
cites | |
container_end_page | 535 |
container_issue | 2 |
container_start_page | 531 |
container_title | Journal of Clinical Microbiology |
container_volume | 35 |
creator | Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.) Diaz-Laviada, M Roy, P Sanchez, C Vela, C Sanchez-Vizcaino, J.M Casal, J.I |
description | Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection |
doi_str_mv | 10.1128/jcm.35.2.531-535.1997 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_9003637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78801896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-4ab7dd91d94af8b32a36115e6b5ad1086679bf762b0f55aa1de8177422e6ca053</originalsourceid><addsrcrecordid>eNqFkU1rFTEUhoMo9Vr9A0IhC3E313xMvhYuStEqFlzUgrtwJpPMTTszqcncSv99c7mXi125OOTA-7wn5_AidEbJmlKmP926ac3Fmq0Fp42oHTVGvUArSoxupCS_X6IVIUY0lHL1Gr0p5ZYQ2rZCnKATQwiXXK3Qj2uf05iG6PAE-c7nguOMPeTxEZcFBl9wCvg85OhgxpuUi8clurvZl4IfYt7u-ODdEtP8Fr0KMBb_7vCeopuvX35dfGuufl5-vzi_apyQdGla6FTfG9qbFoLuOAMuKRVedgJ6SrSUynRBSdaRIAQA7b2mSrWMeemACH6KPu_n3m-7yffOz0uG0d7nWE94tAmifa7McWOH9GAZM5LR6v948Of0Z-vLYqdYnB9HmH3aFqu0JlQb-V-QCl131ayCYg-6nErJPhyXocTu0rI1LcuFZbamVUvYXVrVd_bvJUfXIZ6qfzjoUByMIcPsYjliTLStYaRieI9t4rD5G7O3UKZnX1bk_R4JkCwMuU65uTaq5a0S_AkNK7KS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15867982</pqid></control><display><type>article</type><title>Serologic markers in early stages of African horse sickness virus infection</title><source>Open Access: PubMed Central</source><source>American Society for Microbiology Journals</source><creator>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.) ; Diaz-Laviada, M ; Roy, P ; Sanchez, C ; Vela, C ; Sanchez-Vizcaino, J.M ; Casal, J.I</creator><creatorcontrib>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.) ; Diaz-Laviada, M ; Roy, P ; Sanchez, C ; Vela, C ; Sanchez-Vizcaino, J.M ; Casal, J.I</creatorcontrib><description>Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/jcm.35.2.531-535.1997</identifier><identifier>PMID: 9003637</identifier><identifier>CODEN: JCMIDW</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>African Horse Sickness - immunology ; African horse sickness virus ; African Horse Sickness Virus - immunology ; Animals ; Antibodies, Viral - blood ; Antigens, Viral ; Biological and medical sciences ; Blotting, Western ; Capsid - immunology ; Capsid Proteins ; Experimental viral diseases and models ; INFECCION ; INFECTION ; Infectious diseases ; Medical sciences ; Vaccination ; Viral diseases ; Viral Proteins - immunology ; Viral Vaccines - immunology ; VIRUS DE LA PESTE EQUINA AFRICANA ; VIRUS PESTE EQUINE AFRICAINE</subject><ispartof>Journal of Clinical Microbiology, 1997-02, Vol.35 (2), p.531-535</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-4ab7dd91d94af8b32a36115e6b5ad1086679bf762b0f55aa1de8177422e6ca053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC229621/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC229621/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,733,786,790,891,3207,3208,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2544920$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9003637$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.)</creatorcontrib><creatorcontrib>Diaz-Laviada, M</creatorcontrib><creatorcontrib>Roy, P</creatorcontrib><creatorcontrib>Sanchez, C</creatorcontrib><creatorcontrib>Vela, C</creatorcontrib><creatorcontrib>Sanchez-Vizcaino, J.M</creatorcontrib><creatorcontrib>Casal, J.I</creatorcontrib><title>Serologic markers in early stages of African horse sickness virus infection</title><title>Journal of Clinical Microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection</description><subject>African Horse Sickness - immunology</subject><subject>African horse sickness virus</subject><subject>African Horse Sickness Virus - immunology</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens, Viral</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Capsid - immunology</subject><subject>Capsid Proteins</subject><subject>Experimental viral diseases and models</subject><subject>INFECCION</subject><subject>INFECTION</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Vaccination</subject><subject>Viral diseases</subject><subject>Viral Proteins - immunology</subject><subject>Viral Vaccines - immunology</subject><subject>VIRUS DE LA PESTE EQUINA AFRICANA</subject><subject>VIRUS PESTE EQUINE AFRICAINE</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkU1rFTEUhoMo9Vr9A0IhC3E313xMvhYuStEqFlzUgrtwJpPMTTszqcncSv99c7mXi125OOTA-7wn5_AidEbJmlKmP926ac3Fmq0Fp42oHTVGvUArSoxupCS_X6IVIUY0lHL1Gr0p5ZYQ2rZCnKATQwiXXK3Qj2uf05iG6PAE-c7nguOMPeTxEZcFBl9wCvg85OhgxpuUi8clurvZl4IfYt7u-ODdEtP8Fr0KMBb_7vCeopuvX35dfGuufl5-vzi_apyQdGla6FTfG9qbFoLuOAMuKRVedgJ6SrSUynRBSdaRIAQA7b2mSrWMeemACH6KPu_n3m-7yffOz0uG0d7nWE94tAmifa7McWOH9GAZM5LR6v948Of0Z-vLYqdYnB9HmH3aFqu0JlQb-V-QCl131ayCYg-6nErJPhyXocTu0rI1LcuFZbamVUvYXVrVd_bvJUfXIZ6qfzjoUByMIcPsYjliTLStYaRieI9t4rD5G7O3UKZnX1bk_R4JkCwMuU65uTaq5a0S_AkNK7KS</recordid><startdate>19970201</startdate><enddate>19970201</enddate><creator>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.)</creator><creator>Diaz-Laviada, M</creator><creator>Roy, P</creator><creator>Sanchez, C</creator><creator>Vela, C</creator><creator>Sanchez-Vizcaino, J.M</creator><creator>Casal, J.I</creator><general>American Society for Microbiology</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19970201</creationdate><title>Serologic markers in early stages of African horse sickness virus infection</title><author>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.) ; Diaz-Laviada, M ; Roy, P ; Sanchez, C ; Vela, C ; Sanchez-Vizcaino, J.M ; Casal, J.I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-4ab7dd91d94af8b32a36115e6b5ad1086679bf762b0f55aa1de8177422e6ca053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>African Horse Sickness - immunology</topic><topic>African horse sickness virus</topic><topic>African Horse Sickness Virus - immunology</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens, Viral</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Capsid - immunology</topic><topic>Capsid Proteins</topic><topic>Experimental viral diseases and models</topic><topic>INFECCION</topic><topic>INFECTION</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Vaccination</topic><topic>Viral diseases</topic><topic>Viral Proteins - immunology</topic><topic>Viral Vaccines - immunology</topic><topic>VIRUS DE LA PESTE EQUINA AFRICANA</topic><topic>VIRUS PESTE EQUINE AFRICAINE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.)</creatorcontrib><creatorcontrib>Diaz-Laviada, M</creatorcontrib><creatorcontrib>Roy, P</creatorcontrib><creatorcontrib>Sanchez, C</creatorcontrib><creatorcontrib>Vela, C</creatorcontrib><creatorcontrib>Sanchez-Vizcaino, J.M</creatorcontrib><creatorcontrib>Casal, J.I</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Clinical Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez-Torrecuadrada, J.L. (INGENASA, Madrid.)</au><au>Diaz-Laviada, M</au><au>Roy, P</au><au>Sanchez, C</au><au>Vela, C</au><au>Sanchez-Vizcaino, J.M</au><au>Casal, J.I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serologic markers in early stages of African horse sickness virus infection</atitle><jtitle>Journal of Clinical Microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>1997-02-01</date><risdate>1997</risdate><volume>35</volume><issue>2</issue><spage>531</spage><epage>535</epage><pages>531-535</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><coden>JCMIDW</coden><notes>L73</notes><notes>9743475</notes><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-1</notes><notes>content type line 23</notes><notes>ObjectType-Article-1</notes><notes>ObjectType-Feature-2</notes><abstract>Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>9003637</pmid><doi>10.1128/jcm.35.2.531-535.1997</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0095-1137 |
ispartof | Journal of Clinical Microbiology, 1997-02, Vol.35 (2), p.531-535 |
issn | 0095-1137 1098-660X |
language | eng |
recordid | cdi_pubmed_primary_9003637 |
source | Open Access: PubMed Central; American Society for Microbiology Journals |
subjects | African Horse Sickness - immunology African horse sickness virus African Horse Sickness Virus - immunology Animals Antibodies, Viral - blood Antigens, Viral Biological and medical sciences Blotting, Western Capsid - immunology Capsid Proteins Experimental viral diseases and models INFECCION INFECTION Infectious diseases Medical sciences Vaccination Viral diseases Viral Proteins - immunology Viral Vaccines - immunology VIRUS DE LA PESTE EQUINA AFRICANA VIRUS PESTE EQUINE AFRICAINE |
title | Serologic markers in early stages of African horse sickness virus infection |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T11%3A34%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serologic%20markers%20in%20early%20stages%20of%20African%20horse%20sickness%20virus%20infection&rft.jtitle=Journal%20of%20Clinical%20Microbiology&rft.au=Martinez-Torrecuadrada,%20J.L.%20(INGENASA,%20Madrid.)&rft.date=1997-02-01&rft.volume=35&rft.issue=2&rft.spage=531&rft.epage=535&rft.pages=531-535&rft.issn=0095-1137&rft.eissn=1098-660X&rft.coden=JCMIDW&rft_id=info:doi/10.1128/jcm.35.2.531-535.1997&rft_dat=%3Cproquest_pubme%3E78801896%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c561t-4ab7dd91d94af8b32a36115e6b5ad1086679bf762b0f55aa1de8177422e6ca053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15867982&rft_id=info:pmid/9003637&rfr_iscdi=true |